Analysts expect record year for Carl Zeiss Med.

Tomorrow the German company Carl Zeiss Med. will publish her results over the past quarter. For this year the consensus of the revenue equals 1,1 billion euros. The expectations would mean a record revenue for the company. This is slightly more than the revenue over 2015 of 1,04 billion euros.

Historical revenues and results Carl Zeiss Med. plus taxations 2016

The analysts expect for 2016 a net profit of 96 million euros. For the current year the consensus of the result per share is a profit of 1,2 euros. Based on this the price/earnings-ratio equals 27,98.

The average of the dividends estimates is at 0,5 cent. Carl Zeiss Med.'s dividend return consequently equals 1,49 percent. The average dividend of the pharmaceutical sector equals a quite low 0,38 percent.

Most recent target prices around 36 euros

Carl Zeiss Med. is being covered by 10 analysts (only based on fundamental analysis). The average target price for the stock is at 30,77 euros. This is around 8 percent less than the current stock price of 33,58 euros. HSBC , Berenberg and Independent Research recently provided recommendations for the company.

Based on the number of outstanding shares Carl Zeiss Med.'s market capitalization equals 2,73 billion euros.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.